Answers are grounded in this paper and cite their sources.
Hepatocellular carcinoma (HCC) is characterized by high incidence and mortality, representing a significant threat to human health. Peroxisomes are known to play crucial roles in hepatic fatty acid metabolism. Given that aberrant fatty acid metabolism is one of the hallmarks of HCC, it is essential to explore hepatocarcinogenesis from the perspective of peroxisomal fatty acid metabolism. HCC was induced in the offspring of a grandmaternal and/or maternal obesity model established using a high-fat diet (HFD), with diethylnitrosamine (DEN) as the carcinogen. RNA sequencing was performed to identify potential HCC driver genes. Immunoprecipitation combined with mass spectrometry was employed to identify the proteins undergoing succinylation. Protein–protein interaction was predicted and modeled by AlphaFold3 and validated by co-immunoprecipitation. We reported an anti-HCC role of the peroxisomal bifunctional enzyme (PBE), EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase). In mouse and clinical HCC samples, EHHADH levels were decreased compared with normal or para-HCC tissues, while in HCC tissues with steatosis, EHHADH levels were further reduced relative to HCC tissues without steatosis. In vitro and in vivo results demonstrated that deletion of EHHADH significantly accelerated, while overexpression of EHHADH suppressed, HCC proliferation. Moreover, EHHADH deficiency decreased total protein succinylation levels in HCC cells. Mechanistically, EHHADH increased the succinylation level of dihydrolipoamide S-succinyltransferase (DLST), the E2 subunit of α-ketoglutarate dehydrogenase complex (α-KGDH), one of the rate-limiting enzymes of the tricarboxylic acid cycle in mitochondria. Further studies indicated that succinylation of DLST on lysine 286 (K286) attenuated the interaction between DLST and 2-oxoglutarate dehydrogenase (OGDH), the E1 subunit of α-KGDH, and thereby reduced the activity of α-KGDH holoenzyme. Blocking DLST succinylation at K286 promoted, while upregulation of DLST succinylation suppressed, HCC proliferation driven by EHHADH deficiency in xenografts. An anti-HCC role of EHHADH, which suppresses α-KGDH activity by inducing DLST succinylation, is suggested in HCC progression. Not applicable.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: